image
Healthcare - Medical - Diagnostics & Research - NASDAQ - CN
$ 3.75
1.35 %
$ 36.3 M
Market Cap
-0.49
P/E
CASH FLOW STATEMENT
-256 M OPERATING CASH FLOW
44.01%
-9.3 M INVESTING CASH FLOW
-24.61%
-48.8 M FINANCING CASH FLOW
43.38%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Burning Rock Biotech Limited
image
Net Income -654 M
Depreciation & Amortization 133 M
Capital Expenditures -9.38 M
Stock-Based Compensation 261 M
Change in Working Capital -52.2 M
Others -9.98 M
Free Cash Flow -265 M

Cash Flow

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
OPERATING CASH FLOW
Net Income (653.7) (971.2) (796.7) (407.2) (169.2) (177.5) (131.3)
Depreciation & Amortization 133.4 124.1 47.8 33.3 31.4 24.7 21.3
Deferred Income Tax 0 0 15.4 0 15.6 1.4 1.2
Stock Based Compensation 260.7 326.8 282.4 173.2 22.8 5.1 4.1
Other Operating Activities 55.9 57.2 35.6 15.1 1.8 3.7 5.8
Change in Working Capital (52.2) 6.3 (62.4) 112.1 (130.5) (6.2) (34.8)
Cash From Operations (255.8) (456.8) (477.9) (73.5) (228.0) (148.8) (133.7)
INVESTING CASH FLOW
Capital Expenditures (9.4) (62.0) (213.4) (79.5) (45.7) (24.7) (23.0)
Other Items 84 K 54.6 295.1 (29.8) (300.9) 130.8 (168.1)
Cash From Investing Activities (9.3) (7.5) 81.7 (109.3) (346.7) 106.1 (191.1)
FINANCING CASH FLOW
Common Stock Repurchased (7.0) (71.8) (4.3) 0 (3.6) (1.5) (9.1)
Total Debt Repaid 0 (2.4) (44.8) (20.6) (81.6) 82.9 11.4
Dividends Paid 0 0 0 0 0 0 0
Other Financing Activities (41.9) (12.0) (3.8) 334.4 657.0 0.5 351.8
Cash From Financing Activities (48.8) (86.2) (52.9) 2 165.7 571.7 83.4 354.2
CHANGE IN CASH
Net Change In Cash (310.1) (513.8) (486.1) 1 827.0 2.9 40.5 18.0
FREE CASH FLOW
Free Cash Flow (265.2) (518.8) (691.3) (153.1) (273.8) (173.5) (156.7)